Used in pharmaceutical research and development as a lipophilic prodrug derivative to enhance the dermal or transdermal delivery of rosuvastatin. Its increased lipid solubility improves skin permeability, making it a candidate for topical formulations aimed at treating localized inflammation, oxidative stress, or skin conditions associated with lipid imbalance. Also explored in drug delivery systems to improve bioavailability and prolong therapeutic effect compared to the parent compound. Investigated for potential use in sustained-release formulations and targeted therapies where controlled conversion to active rosuvastatin is required.